Dose Dutasteride Reduce Surgical Blood Loss for Benign Prostatic Hyperplasia Patients? More Information Is Needed

Publisher： Karger

E-ISSN： 1423-0399|98|4|489-489

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.98, Iss.4, 2017-04, pp. : 489-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pre-Surgical Finasteride Therapy in Patients Treated Endoscopically for Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 74, Iss. 1, 2005-01 ,pp. : 51-53

Karger

Access to resources Recommend Favorite

Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia

By Shergill Iqbal S   Barua Jayanta M  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 383-386

Future Medicine

Access to resources Recommend Favorite

How Do Patients with Familial Benign Prostatic Hyperplasia Differ Clinically from Those with Sporadic Benign Prostatic Hyperplasia?

By  

Urologia Internationalis, Vol. 76, Iss. 4, 2006-05 ,pp. : 332-334

Karger

Access to resources Recommend Favorite

Body Mass Index Predicts Failure of Surgical Management in Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-12 ,pp. : 150-155

Karger

Access to resources Recommend Favorite

Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital

By  

ANZ JOURNAL OF SURGERY, Vol. 88, Iss. 1-2, 2018-01 ,pp. : 95-99

John Wiley & Sons Inc

Access to resources Recommend Favorite